Pim kinase inhibitors and methods of their use

Details for Australian Patent Application No. 2009221134 (hide)

Owner Novartis AG

Inventors Lan, Jiong; Lindvall, Mika; Tetalman, Michelle; Burger, Matthew; Nishiguchi, Gisele

Agent Davies Collison Cave

Pub. Number AU-B-2009221134

PCT Pub. Number WO2009/109576

Priority 61/033,359 03.03.08 US

Filing date 3 March 2009

Wipo publication date 11 September 2009

Acceptance publication date 23 February 2012

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4439 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/109576 Priority application(s): WO2009/109576

23 February 2012 Application Accepted

  Published as AU-B-2009221134

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221154-The development and implementation of an adaptive filter technique for the assessment of circulatory collapse.

2009221129-Marine security system